Recommendations for intraoperative lymph node evaluation are uniform regardless of whether a primary tumor is clinical T1a or T2a according to TNM 8th edition for stage I non-small cell lung cancer (NSCLC). We quantified nodal disease risk in patients with T1a disease (≤1 cm).
Mandatory Nodal Evaluation During Resection of Clinical T1a Non-Small Cell Lung Cancers
Submitted by: Christopher Anderson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2021.06.078
Keywords:
Author(s): Aaron R. Dezube, MD
Emanuele Mazzola, PhD
Ashley Deeb, MD
Daniel C. Wiener, MD
M. Blair Marshall, MD
Mathew W. Rochefort, MD
Michael T. Jaklitsch, MD
